Stockreport

FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A [Yahoo! Finance]

ITOCHU CORP UNSP/ADR  (ITOCY) 
NASDAQ:AMEX Investor Relations: itochu.co.jp/en/ir/index.html
PDF KS) and Novel Pharma have announced that the U.S. FDA has granted Fast Track Designation for their jointly developed MPSIIIA (Sanfilippo syndrome Type A) treatment, GC11 [Read more]